Objective: Adrenal failure, a treatable condition, can have catastrophic co
nsequences if unrecognized in critically ill ED patients. The authors' obje
ctive was; to prospectively study adrenal function in a case,series of hemo
dynamically unstable (highrisk) patients from a large, urban ED over a 12-m
onth period. Methods: In a prospective manner, critically ill adult patient
s presenting to the ED were enrolled when presenting with a: mean arterial
blood pressure less than or equal to 60 mm Hg requiring vasopressor therapy
for more than one: hour after receiving fluid resuscitation (central venou
s pressure of 12-15 mm Hg or a minimum of 40 mL/kg of crystalloid). Patient
s were excluded if presenting with hemorrhage, trauma, or AIDS, or if stero
ids were used, within the previous six months. An adrenocorticotropic hormo
ne (ACTH) stimulation test was performed and serum cortisol was measured. T
reatment for adrenal insufficiency was not instituted. Results: A total of
57 consecutive patients were studied. Of these, eight (14%) had baseline se
rum cortisol concentrations of <20 mu g/dL (<552 nmol/L), which was conside
red adrenal insufficiency (AI). Three additional patients (5%) had subnorma
l 60-minute post-ACTH-stimulation cortisol responses (<30. mu g/dL) and a d
elta cortisol less than or equal to 9 mu g/dL, which is the difference betw
een the baseline and 60-minute levels. This is functional hypoadrenalism (F
H). There were no laboratory abnormalities that distinguished patients with
AI or FH from those with presented adrenal function (PAF). Rates of surviv
al to discharge did not differ between the Al group (7 of 8) and PAF patien
ts (21 of 46; p = 0.052). Conclusions: Adrenal dysfunction is common in hig
h-risk ED patients. Overall, it has a frequency of 19% among a homogeneous
population of hemodynamically unstable vasopressor-dependent patients. The
effect of physiologic glucocorticoid replacement in this setting remains to
be determined.